This paper draws explicitly on the field experiences of two doctoral researchers in geography to elucidate some of the challenges and issues related to researcher vulnerability that are especially acute for graduate students. In spite of significant differences in context, both researchers experienced an unanticipated degree of professional vulnerability during their doctoral fieldwork that warrants further exploration, including a theoretical interrogation of the complex (and shifting) terrain of power relations within qualitative research projects. This paper addresses the lacuna in the qualitative methodological research literature on the topic of researcher vulnerability (in contrast to the well-developed discussion of participant vulnerability). Throughout, the authors suggest possible strategies for mitigating researcher vulnerability while protecting the overall integrity of the research process.

The landscape of community pharmacy practice is changing rapidly across Canada. New pharmacy service frameworks are being implemented across the country, giving community pharmacists the ability to prescribe, inject medications and provide routine medication reviews. 1 With the implementation of new service frameworks, increased emphasis on working within a patientcentred care model and the intensifying need for accessible health care services, community pharmacists are currently facing pressure to shift from "providing products" to "providing patient care services. " 2 This shift is supported by existing and emerging technologies as well as regulatory changes that have expanded pharmacists' scope of practice and allowed pharmacy technicians to play a larger role in dispensing medications. [3][4][5] Still, the majority of patients in community pharmacies see themselves as customers 6 and consequently view pharmacists' main role as provision of medication information rather than clinical services. 7 Pharmacists can change this by increasing engagement with patients in order to provide patient-centred care in community pharmacies. 8,9 For many pharmacists, the process of actively increasing engagement with patients may require a new understanding of patient-pharmacist relationships and development of new skills. 10 The purpose of this article is to introduce the Connect and CARE model to increase pharmacist patient engagement.Connect and CARE is an evidence-based practice model with affiliated tools that will help community pharmacists shift from a productcentred to a patient-centred practice. 11 The evidence for the engagement strategies predominantly arises from the medical literature, includ-

No abstract

No abstract

Self-Disclosure in Psychotherapy, by Dr. Barry Farber, focuses on disclosure dynamics between client and therapist in individual therapy. Three purposes are delineated: (a) to provide historical context to the growing interest in disclosure issues in the United States; (b) to integrate empirical, clinical, and theoretical viewpoints of disclosure in psychotherapy; and (c) to practically bring together research fi ndings from pertinent research communities. The book is intended for therapists and counsellors from all professional backgrounds as well as graduate-level students.Dr. Farber is a professor of psychology and education, and director of the Clinical Psychology Training Program at Teachers College, Columbia University. He obtained a Ph.D. in clinical psychology from Yale University and received training in behavioural, client-centred, and psychodynamically oriented psychotherapies. Spawned in the early 1980s, Dr. Farber's special appreciation for disclosure dynamics in the therapeutic encounter resulted in his steady research on the topic. His strong presence in the psychotherapy research community, and his work alongside other researchers with a similar focus, situates him well in providing this comprehensive contemporary analysis.The book is neatly divided into two sections. It begins with a discussion of the general nature of interpersonal disclosure, which serves as a springboard to separately address "patient" and therapist disclosure. Disclosure in supervisory relationships is also acknowledged, and clinical examples are provided throughout.Four chapters are devoted to patient disclosure (PD), addressing clinical, research, and multicultural perspectives. In chapter 2, conceptualizations of PD according to psychodynamic, humanistic, and cognitive behavioural orientations are provided, followed by brief mention of therapies utilizing nonverbal disclosure as a means of expressing, accessing, and healing emotions. A range of empirically supported variables infl uential to patients' tendency to disclose, as well as positive and negative consequences of disclosing in therapy, are covered.In chapter 3, Dr. Farber draws largely on his research to address topics that patients are least and most comfortable discussing in therapy, and he speaks to the interplay of PD and factors such as shame, therapeutic alliance, and length of therapy. He summarizes the patient view of disclosure as "I'll tell you many things, but I won't tell you everything."The outcome controversy-whether or not disclosure unambiguously leads to therapeutic improvement-is introduced in chapter 4. To this end, Dr. Farber cites research that supports and opposes a positive connection between disclosure and outcome, while identifying methodological and conceptual issues that arguably cloud